Holen Sie sich die Stockscreener-App
3.28
1.23%
0.04
Handel nachbörslich:
3.28
Schlusskurs vom Vortag:
$3.24
Offen:
$3.41
24-Stunden-Volumen:
235.80K
Relative Volume:
0.51
Marktkapitalisierung:
$74.33M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-3.4894
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
-6.55%
1M Leistung:
-36.31%
6M Leistung:
-66.08%
1J Leistung:
-23.19%
1-Tages-Spanne:
$3.23
$3.41
1-Wochen-Bereich:
$3.18
$3.69
52-Wochen-Spanne:
$2.77
$12.23
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Compare XGN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
3.28 | 73.43M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
How interest rate cuts could boost Exagen Inc. stock2025 Macro Impact & Smart Swing Trading Alerts - mfd.ru
Returns Recap: Can Exagen Inc maintain sales growthWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
What Analysts Think Is Changing The Story For Exagen (XGN) Now - Yahoo Finance
Exagen Inc. (NASDAQ:XGN) Short Interest Down 67.3% in January - MarketBeat
Aug EndMonth: Is NVMI exposed to political risk2025 Price Momentum & Daily Stock Trend Watchlist - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Trend Recap: Is Exagen Inc being accumulated by smart moneyWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Performance Recap: Is HBANM a speculative investmentRecession Risk & Technical Pattern Based Buy Signals - baoquankhu1.vn
Quarterly Earnings: Is Exagen Inc being accumulated by smart moneyJuly 2025 PostEarnings & Capital Efficient Trading Techniques - baoquankhu1.vn
B. Riley Reaffirms Buy Rating for Exagen (NASDAQ:XGN) - Defense World
Short Interest in Exagen Inc. (NASDAQ:XGN) Expands By 65.7% - MarketBeat
B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating - marketscreener.com
XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus
Exagen's (XGN) "Buy" Rating Reaffirmed at B. Riley - MarketBeat
Is Exagen Inc. impacted by rising rates2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
What are Exagen Inc.’s recent SEC filings showingWeekly Gains Summary & Weekly Return Optimization Plans - mfd.ru
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target - Yahoo Finance
Volume Recap: Does Crescent Capital BDC Inc stock reflect fundamentals2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
Benign Growth For Exagen Inc. (NASDAQ:XGN) Underpins Stock's 26% Plummet - 富途牛牛
Trend Report: Will Exagen Inc benefit from current market trendsTrade Entry Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Sees Large Growth in Short Interest - MarketBeat
Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm
Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm
Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ
Published on: 2026-01-13 10:11:31 - ulpravda.ru
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story - Yahoo Finance
Exagen Announces Record 2025 Revenue and Strong Cash Position - TipRanks
Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges - Investing.com Canada
California-based Exagen preliminary revenue up 19% in FY25 - Medical Buyer
Exagen (XGN) Reports Strong Annual Growth and Strategic Advances - GuruFocus
Exagen Inc. Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Record Revenue Growth - Quiver Quantitative
Exagen Inc. Announces Select Preliminary 2025 Financial Results - Bluefield Daily Telegraph
Autoimmune testing firm Exagen ends 2025 with record sales and more cash - Stock Titan
Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - Улправда
T Inc Class stock compares with tech leaders2025 Top Gainers & Safe Capital Allocation Plans - ulpravda.ru
Aug Macro: What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - ulpravda.ru
Is Exagen Inc. stock positioned well for digital economyMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What margin trends mean for Exagen Inc. stockEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru
What makes Exagen Inc. stock attractive to growth funds2025 Market Overview & Stock Portfolio Risk Management - ulpravda.ru
Revenue Check: Can Huron Consulting Group Inc. stock deliver surprise earnings beat2025 Macro Impact & AI Forecast Swing Trade Picks - ulpravda.ru
2026 world cup usa squad group stage veteran players set piece strategy knockout prediction analysis - ulpravda.ru
ulpravda ru > 2026> Will LIMN stock beat EPS estimatesQuarterly Trade Summary & High Conviction Buy Zone Picks - ulpravda.ru
Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - Улправда
Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - ulpravda.ru
How ImmunityBio Inc. stock trades before earningsJuly 2025 Sector Moves & Real-Time Market Trend Scan - ulpravda.ru
Can Exagen Inc. (E08A) stock reach $200 price targetWeekly Gains Report & Community Consensus Picks - Улправда
Is MIMI stock a smart buy before Fed meetingWeekly Trade Summary & Low Risk High Reward Ideas - ulpravda.ru
ulpravda ru > 2026> Is BPYPO stock dividend yield sustainableMarket Risk Analysis & Fast Entry High Yield Tips - ulpravda.ru
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Exagen Inc-Aktie (XGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Black Jeffrey G. | Chief Financial Officer |
Sep 02 '25 |
Sale |
9.79 |
20,466 |
200,362 |
269,026 |
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Mar 25 '25 |
Sale |
3.30 |
350,000 |
1,155,000 |
1,758,958 |
0.00%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):